17-TRIFLUOROMETHYLPHENYL TRINOR PROSTAGLANDIN F2ALPHA
Modify Date: 2024-01-09 13:42:28
17-TRIFLUOROMETHYLPHENYL TRINOR PROSTAGLANDIN F2ALPHA structure
|
Common Name | 17-TRIFLUOROMETHYLPHENYL TRINOR PROSTAGLANDIN F2ALPHA | ||
|---|---|---|---|---|
| CAS Number | 221246-34-0 | Molecular Weight | 456.495 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 600.0±50.0 °C at 760 mmHg | |
| Molecular Formula | C24H31F3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 316.6±30.1 °C | |
Use of 17-TRIFLUOROMETHYLPHENYL TRINOR PROSTAGLANDIN F2ALPHA17-trifluoromethylphenyl trinor Prostaglandin F2α bears an aromatic ring, and acts very much like the free acid of travoprost. |
| Name | (1R,2S,3R)-3-ethyl-2-[(3S)-3-hydroxy-5-[3-(trifluoromethyl)phenyl]pent-1-enyl]cyclopentan-1-ol |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 600.0±50.0 °C at 760 mmHg |
| Molecular Formula | C24H31F3O5 |
| Molecular Weight | 456.495 |
| Flash Point | 316.6±30.1 °C |
| Exact Mass | 456.212372 |
| PSA | 97.99000 |
| LogP | 2.69 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.575 |
![(3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxy-5-(3-(trifluoromethyl)phenyl)pent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one structure](https://image.chemsrc.com/caspic/247/294856-05-6.png)
![(3aR,4R,5R,6aS)-2-oxo-4-((E)-3-oxo-5-(3-(trifluoromethyl)phenyl)pent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl benzoate structure](https://image.chemsrc.com/caspic/323/294856-03-4.png)
![(3aR,4R,5R,6aS)-4-((S,E)-3-hydroxy-5-(3-(trifluoromethyl)phenyl)pent-1-en-1-yl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate structure](https://image.chemsrc.com/caspic/285/294856-04-5.png)
![(3aR,4R,5R,6aS)-5-((tetrahydro-2H-pyran-2-yl)oxy)-4-((3S,E)-3-((tetrahydro-2H-pyran-2-yl)oxy)-5-(3-(trifluoromethyl)phenyl)pent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one structure](https://image.chemsrc.com/caspic/209/294856-06-7.png)
| Precursor 9 | |
|---|---|
| DownStream 0 | |
| (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(1E,3S)-3-hydroxy-5-[3-(trifluoromethyl)phenyl]-1-penten-1-yl}cyclopentyl]-5-heptenoic acid |
| 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-[3-(trifluoromethyl)phenyl]-1-penten-1-yl]cyclopentyl]-, (5Z)- |
| (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3S)-3-hydroxy-5-[3-(trifluoromethyl)phenyl]pent-1-en-1-yl}cyclopentyl]hept-5-enoic acid |
| (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(1E,3S)-3-hydroxy-5-[4-(trifluoromethyl)phenyl]-1-penten-1-yl}cyclopentyl]-5-heptenoic acid |
| 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-[4-(trifluoromethyl)phenyl]-1-penten-1-yl]cyclopentyl]-, (5Z)- |
| 17-trifluoromethylphenyl trinor Prostaglandin F2alpha |